Literature DB >> 22818108

Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques.

Matthew H G Katz1, Jeffrey E Lee, Peter W T Pisters, Roman Skoracki, Eric Tamm, Jason B Fleming.   

Abstract

Pancreatectomy with aggressive vascular resection is increasingly being recognized as an appropriate treatment strategy for patients with borderline resectable PDAC after administration of chemotherapy and/or chemoradiation. Because tumor downstaging is an uncommon event, both venous and hepatic arterial resection and reconstruction might be necessary to achieve negative surgical margins and the favorable short-term and long-term outcomes we have reported previously. The technical approaches we have described here can be used as a basic foundation for operative safety and efficiency during these challenging operations.

Entities:  

Mesh:

Year:  2012        PMID: 22818108      PMCID: PMC4637976          DOI: 10.1016/j.jamcollsurg.2012.05.015

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  14 in total

1.  Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer.

Authors:  Matthew H G Katz; Huamin Wang; Aparna Balachandran; Priya Bhosale; Christopher H Crane; Xuemei Wang; Peter W T Pisters; Jeffrey E Lee; Jean-Nicolas Vauthey; Eddie K Abdalla; Robert Wolff; James Abbruzzese; Gauri Varadhachary; Xavier Chopin-Laly; Chusilp Charnsangavej; Jason B Fleming
Journal:  J Gastrointest Surg       Date:  2011-11-08       Impact factor: 3.452

2.  Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Authors:  Ross A Abrams; Andrew M Lowy; Eileen M O'Reilly; Robert A Wolff; Vincent J Picozzi; Peter W T Pisters
Journal:  Ann Surg Oncol       Date:  2009-04-24       Impact factor: 5.344

3.  Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.

Authors:  Mark P Callery; Kenneth J Chang; Elliot K Fishman; Mark S Talamonti; L William Traverso; David C Linehan
Journal:  Ann Surg Oncol       Date:  2009-04-24       Impact factor: 5.344

Review 4.  A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer.

Authors:  Alessio G Morganti; Mariangela Massaccesi; Giuseppe La Torre; Luciana Caravatta; Adele Piscopo; Rosa Tambaro; Luigi Sofo; Giuseppina Sallustio; Marcello Ingrosso; Gabriella Macchia; Francesco Deodato; Vincenzo Picardi; Edy Ippolito; Numa Cellini; Vincenzo Valentini
Journal:  Ann Surg Oncol       Date:  2009-10-24       Impact factor: 5.344

5.  Quantitative weighting of postoperative complications based on the accordion severity grading system: demonstration of potential impact using the american college of surgeons national surgical quality improvement program.

Authors:  Matthew R Porembka; Bruce Lee Hall; Mitzi Hirbe; Steven M Strasberg
Journal:  J Am Coll Surg       Date:  2010-03       Impact factor: 6.113

6.  Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.

Authors:  Matthew H G Katz; Nipun B Merchant; Steven Brower; Megan Branda; Mitchell C Posner; L William Traverso; Ross A Abrams; Vincent J Picozzi; Peter W T Pisters
Journal:  Ann Surg Oncol       Date:  2010-09-01       Impact factor: 5.344

7.  Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators.

Authors:  Matthew H G Katz; Jason B Fleming; Priya Bhosale; Gauri Varadhachary; Jeffrey E Lee; Robert Wolff; Huamin Wang; James Abbruzzese; Peter W T Pisters; Jean-Nicolas Vauthey; Chusilp Charnsangavej; Eric Tamm; Christopher H Crane; Aparna Balachandran
Journal:  Cancer       Date:  2012-05-17       Impact factor: 6.860

8.  Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

Authors:  Jayme B Stokes; Norris J Nolan; Edward B Stelow; Dustin M Walters; Geoffrey R Weiss; Eduard E de Lange; Tyvin A Rich; Reid B Adams; Todd W Bauer
Journal:  Ann Surg Oncol       Date:  2011-01-07       Impact factor: 5.344

9.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Authors:  Jennifer F Tseng; Chandrajit P Raut; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Henry F Gomez; Charlotte C Sun; Christopher H Crane; Robert A Wolff; Douglas B Evans
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

Review 10.  Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.

Authors:  Gauri R Varadhachary; Eric P Tamm; James L Abbruzzese; Henry Q Xiong; Christopher H Crane; Huamin Wang; Jeffrey E Lee; Peter W T Pisters; Douglas B Evans; Robert A Wolff
Journal:  Ann Surg Oncol       Date:  2006-07-24       Impact factor: 5.344

View more
  13 in total

1.  Short-term but not long-term loss of patency of venous reconstruction during pancreatic resection is associated with decreased survival.

Authors:  Irmina Gawlas; Irene Epelboym; Megan Winner; Joseph DiNorcia; Yanghee Woo; James L Lee; Beth A Schrope; John A Chabot; John D Allendorf
Journal:  J Gastrointest Surg       Date:  2013-10-10       Impact factor: 3.452

2.  Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality.

Authors:  Jason W Denbo; Morgan L Bruno; Jordan M Cloyd; Laura Prakash; Jeffrey E Lee; Michael Kim; Christopher H Crane; Eugene J Koay; Sunil Krishnan; Prajnan Das; Bruce D Minsky; Gauri Varadhachary; Rachna Shroff; Robert Wolff; Milind Javle; Michael J Overman; David Fogelman; Thomas A Aloia; Jean-Nicolas Vauthey; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2016-10-11       Impact factor: 3.452

3.  Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Jordan M Cloyd; Christopher H Crane; Eugene J Koay; Prajnan Das; Sunil Krishnan; Laura Prakash; Rebecca A Snyder; Gauri R Varadhachary; Robert A Wolff; Milind Javle; Rachna T Shroff; David Fogelman; Michael Overman; Huamin Wang; Anirban Maitra; Jeffrey E Lee; Jason B Fleming; Matthew H G Katz
Journal:  Cancer       Date:  2016-05-31       Impact factor: 6.860

4.  Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy.

Authors:  Jordan M Cloyd; Graciela M Nogueras-González; Laura R Prakash; Maria Q B Petzel; Nathan H Parker; An T Ngo-Huang; David Fogelman; Jason W Denbo; Naveen Garg; Michael P Kim; Jeffrey E Lee; Ching-Wei D Tzeng; Jason B Fleming; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2017-12-11       Impact factor: 3.452

5.  Splenic artery use for arterial reconstruction in pancreatic surgery.

Authors:  Thilo Hackert; Jürgen Weitz; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2014-05-01       Impact factor: 3.445

6.  Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.

Authors:  Jordan M Cloyd; Matthew H G Katz; Laura Prakash; Gauri R Varadhachary; Robert A Wolff; Rachna T Shroff; Milind Javle; David Fogelman; Michael Overman; Christopher H Crane; Eugene J Koay; Prajnan Das; Sunil Krishnan; Bruce D Minsky; Jeffrey H Lee; Manoop S Bhutani; Brian Weston; William Ross; Priya Bhosale; Eric P Tamm; Huamin Wang; Anirban Maitra; Michael P Kim; Thomas A Aloia; Jean-Nicholas Vauthey; Jason B Fleming; James L Abbruzzese; Peter W T Pisters; Douglas B Evans; Jeffrey E Lee
Journal:  J Gastrointest Surg       Date:  2016-10-24       Impact factor: 3.452

7.  Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection.

Authors:  Laura R Prakash; Huamin Wang; Jun Zhao; Graciela M Nogueras-Gonzalez; Jordan M Cloyd; Ching-Wei D Tzeng; Michael P Kim; Jeffrey E Lee; Matthew H G Katz
Journal:  J Gastrointest Surg       Date:  2019-02-28       Impact factor: 3.452

8.  Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study.

Authors:  Federico Selvaggi; Giuseppe Mascetta; Despoina Daskalaki; Marco dal Molin; Roberto Salvia; Giovanni Butturini; Carlo Cellini; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2014-04-30       Impact factor: 3.445

9.  Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma.

Authors:  Suguru Yamashita; Michael J Overman; Huamin Wang; Jun Zhao; Masayuki Okuno; Claire Goumard; Ching-Wei Tzeng; Michael Kim; Jason B Fleming; Jean-Nicolas Vauthey; Matthew H Katz; Jeffrey E Lee; Claudius Conrad
Journal:  Ann Surg Oncol       Date:  2017-10-04       Impact factor: 5.344

10.  Clinical Outcome of Ampullary Carcinoma: Single Cancer Center Experience.

Authors:  Mohammed Al-Jumayli; Amna Batool; Akshay Middiniti; Anwaar Saeed; Weijing Sun; Raed Al-Rajabi; Joaquina Baranda; Sean Kumer; Timothy Schmitt; Anusha Chidharla; Anup Kasi
Journal:  J Oncol       Date:  2019-05-02       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.